Literature DB >> 9357627

Using data mining to characterize DNA mutations by patient clinical features.

S Evans1, S J Lemon, C Deters, R M Fusaro, C Durham, C Snyder, H T Lynch.   

Abstract

In most hereditary cancer syndromes, finding a correspondence between various genetic mutations within a gene (genotype) and a patient's clinical cancer history (phenotype) is challenging; to date there are few clinically meaningful correlations between specific DNA intragenic mutations and corresponding cancer types. To define possible genotype and phenotype correlations, we evaluated the application of data mining methodology whereby the clinical cancer histories of gene-mutation-positive patients were used to define valid or "true" patterns for a specific DNA intragenic mutation. The clinical histories of patients with their corresponding detailed attributes without the same oncologic intragenic mutation were labeled incorrect or "false" patterns. The results of data mining technology yielded characterizing rules for the true cases that constituted clinical features which predicted the intragenic mutation. Some of the initial results derived correlations already independently known in the literature, adding to the confidence of using this methodological approach.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357627      PMCID: PMC2233315     

Source DB:  PubMed          Journal:  Proc AMIA Annu Fall Symp        ISSN: 1091-8280


  10 in total

Review 1.  Heterogeneity and natural history of hereditary breast cancer. Surgical implications.

Authors:  H T Lynch; R J Fitzgibbons; J F Lynch
Journal:  Surg Clin North Am       Date:  1990-08       Impact factor: 2.741

2.  Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1.

Authors:  S C Rubin; I Benjamin; K Behbakht; H Takahashi; M A Morgan; V A LiVolsi; A Berchuck; M G Muto; J E Garber; B L Weber; H T Lynch; J Boyd
Journal:  N Engl J Med       Date:  1996-11-07       Impact factor: 91.245

3.  Artificial neural networks in mammography: application to decision making in the diagnosis of breast cancer.

Authors:  Y Wu; M L Giger; K Doi; C J Vyborny; R A Schmidt; C E Metz
Journal:  Radiology       Date:  1993-04       Impact factor: 11.105

4.  Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.

Authors:  C E Bronner; S M Baker; P T Morrison; G Warren; L G Smith; M K Lescoe; M Kane; C Earabino; J Lipford; A Lindblom
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

5.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

Authors:  R Wooster; S L Neuhausen; J Mangion; Y Quirk; D Ford; N Collins; K Nguyen; S Seal; T Tran; D Averill
Journal:  Science       Date:  1994-09-30       Impact factor: 47.728

6.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

7.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

Authors:  R Fishel; M K Lescoe; M R Rao; N G Copeland; N A Jenkins; J Garber; M Kane; R Kolodner
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

8.  A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.

Authors:  O Serova; M Montagna; D Torchard; S A Narod; P Tonin; B Sylla; H T Lynch; J Feunteun; G M Lenoir
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

9.  A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

Authors:  D Shattuck-Eidens; M McClure; J Simard; F Labrie; S Narod; F Couch; K Hoskins; B Weber; L Castilla; M Erdos
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

10.  Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

Authors:  S A Gayther; W Warren; S Mazoyer; P A Russell; P A Harrington; M Chiano; S Seal; R Hamoudi; E J van Rensburg; A M Dunning; R Love; G Evans; D Easton; D Clayton; M R Stratton; B A Ponder
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

  10 in total
  1 in total

Review 1.  Data mining in the US using the Vaccine Adverse Event Reporting System.

Authors:  John Iskander; Vitali Pool; Weigong Zhou; Roseanne English-Bullard
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.